Introduction of New Members, Staff, Liaisons and Guests – Eric Green and Rudy Pozzatti

Eric Green:
Okay. Well, thank you, everyone. I will call the 67th meeting of the National Advisory
Council for Human Genome Research meeting to order. Thank you all for coming. I will
point out, this is the 67th meeting of this advisory council; it’s actually the 10th meeting
that I’m presiding over as NHGRI director, although it’s only the ninth in-person one.
My first one, three years ago in February, was actually a conference call because of
a snowstorm that prevented us from actually having an in-person meeting. I will also point
out that the gentleman sitting to my left is the new executive secretary of the advisory
council, Rudy Pozzatti. Almost all of you know Rudy; we even gave you a head-fake a
few or a couple councils ago where he was called in from the bullpen at short notice
to preside over council for that one time, but now he is the permanent executive secretary,
so I’ll turn this over to him for the initial set of announcements. Rudy Pozzatti:
Okay, thank you, Eric. Let me remind everyone that we’re video casting the open session
of the council meeting today. It will also be archived, so your mistakes will live beyond
you. [laughter] So before we begin what will be my maiden
voyage as the executive secretary of the council, I’d like to take a moment to acknowledge my
predecessor, Mark Guyer. Mark has served as the executive secretary for 10 years; that’s
30-some council meetings to arrange and organize. Having just gone through the experience myself,
I can tell you, it’s a lot more work than simply arranging some flights to get you all
to be here at the same time, same days. If you do a little bit of math, $350 million
a year for 10 years, that’s a lot of resources that has come before you and your predecessors
here at the council. Go back 10 years, you’re talking about the completion of the Human
Genome Project, the ENCODE project, the HapMap project, tons of technology development, lots
and lots of Common Fund initiatives. I’ll get myself in trouble if I try to recall every
single valuable and important research endeavor that’s come to you. But suffice it to say,
it’s a huge body of work, and one that I think Mark can be proud of. So would you please
take a moment and join me, and thank Mark for 10 years of service to the council. [applause] Okay. Let’s begin with introductions. We have
new council members joining us today. Dr. Lon Cardon is a senior vice president for
alternative discovery and development at GlaxoSmithKline. Among other responsibilities, he leads a group
at GSK doing pharmacology modeling and simulation studies for drug development. Lon has also
applied his statistical genetics expertise to gene discovery studies in complex diseases
including asthma, diabetes, obesity, and many others. He’s also had a leadership role in
large multinational studies including the Welcome Trust Case Control Consortium and
our own beloved HapMap Project. Welcome, Lon. Dr. Joseph Ecker is professor of the plant
molecular and cellular biology laboratory and HHMI investigator at the Salk Institute
for Biological Studies. Joe was one of the leaders of the international effort to map
and sequence the genome of Arabidopsis. More recently, he has studied the epigenome in
human and model organisms, and the role of epigenetic modifications in regulating processes
such as cellular development and carcinogenesis. Welcome, Joe. Dr. Howard Jacob is professor and director
of the Human and Molecular Genetics Center of the Medical College of Wisconsin, and vice
chair for research at the Children’s Hospital of Wisconsin. Howard has a long history of
applying genomic technologies in the rat model organism to the study of complex disorders
such as renal disease, diabetes, hypertension, and myocardial infarction. He’s been PI of
the Rat Genome Database, a resource that has served the scientific community for many,
many years. And more recently, Howard has begun to apply high-throughput sequencing
in the clinical setting to discover genetic variants involved in human disease. Welcome,
Howard. Dr. Lucilla Ohno-Machado is professor of medicine
and chief of the Division of Biomedical Informatics at the University of San Diego. As a principal
investigator in the iDASH consortium, Lucilla has brought expertise in medical informatics
and the analysis of multiple data types. She conducts multidisciplinary research focused
on biomedical pattern recognition in large datasets. And she is involved in policy work
surrounding data access and privacy issues, and Lucilla also has strong interest in informatics
training, both in the U.S. and in international settings. Welcome, Lucilla. Dr. Robert Nussbaum is professor and chief
of Genomic Medicine at the University of California, San Francisco. Bob has a long standing interest
in applying genetic and genomic approaches to mapping diseases in humans, particularly
in neurodegenerative disorders. As a geneticist who provides service to patients, Bob is also
interested in questions surrounding the return of genetic findings to patients, and developing
information resources relevant to clinical genomics. Welcome home, Bob. Arti Rai is the Elvin R. Latti Professor of
Law at Duke University Law School. Arti is an expert in intellectual property law and
health policy law. She has conducted research on IP issues in biotechnology and the pharmaceutical
industries. In 2009-2010, Arti served as the administrator of the Office of External Affairs
at the USPTO and conducted analysis work that was seminal to subsequent patent law reform,
and she has served on President-elect Obama’s transition team in 2008-2009 to review the
USPTO. Welcome, Arti. We also have two special ad-hoc council members
joining us for just this meeting. Dr. Joanne Baughman is senior vice chancellor at the
University System of Maryland, where she oversees the twelve institutions that comprise the
entire University of Maryland system. Prior to her current position, Joanne was executive
vice president of the American Society of Human Genetics for a number of years. She
was the council liaison for ASHGH — ASHG. And she has served for me on many, many peer
review panels. Always good to see you, Joanne. Dr. Pilar Ossorio is associate professor of
law and bioethics at the University of Wisconsin Law School, where she teaches courses on intellectual
property, patent law, and torts. Pilar is in LC grantee, a former council member for
NHGRI, and a former standing study section member of the LC peer review panel that served
both CSR and NHGRI. Nice to have you, Pilar. We have several new employees at NHGRI that
we’re going to introduce to the council. Would you please stand when I call you name? Dr.
Michael Smith. Mike is in the Division Of Genomic Science and the Extramural Research
Program. Mike comes to us from NCI Intramural Research. He has a wealth of experience using
genomic technologies for biomedical studies, and he will be working on a portfolio of grants
related to technology development. Nicole Lockhart. Nicole’s in the Division
of Genomics and Society. She also comes to us from NCI. She has experience working on
research issues related to biorepositories, data access, and ethical questions about the
use of biological samples. I’m sure she’ll be called upon to do a little of everything
in the LC program. Nick Giacomo [spelled phonetically]. Nick
is a new program analyst, and he’ll be splitting his time working on the Undiagnosed Diseases
Program and the Human Microbiome Project. Steve Benowitz. Steve is a new member of the
Communications and Public Liaison staff in the Division of Policy, Communications and
Education. He will cover news and media requests for the extramural research program. He’s
written on genomic for NCI, the American Society of Clinical Oncology, and John Hopkins University. Chris Donohue? Chris is also in the communications
branch of DCPE, and he’ll lead the effort to archive documents about NHGRI’s scientific
legacy. Chris is also working on his doctoral degree at the University of Maryland. Christina Dalton [spelled phonetically]. Christina
is a new education outreach specialist in the Education and Community Involvement branch
of DPCE. Thank you, Christina. We would like to welcome our council liaisons:
Ellen Giarelli from the International Society of Nurses in Genetics; James O’Leary from
the Genetic Alliance; Rhonda Schonberg from the National Society of Genetic Counselors;
and Mike Watson from the American College of Medical Genetics. Welcome all of you, and
thank you for joining us today. We also have a couple of guests in attendance.
Tabitha Hendershot and Mario Renado [spelled phonetically] at Nursing Research. Thank you
for joining us. Is there anyone else that’s attending that
failed to be snagged at the sign-in sheet at the front desk, if you’re courageous enough
to stand up and go to a microphone introduce yourself. Okay, let’s move on to the meeting minutes
from the last council round. At this time, I’d like to ask the council if there are any
corrections or additions to the September 2012 council minutes? If none, can I have
a motion to accept the minutes? Male Speaker:
So moved. Rudy Pozzatti:
Second. All in favor? Anyone possibly opposed to approving the minutes? Thank you. Let me call your attention to the future meeting
dates; it’s on the open session agenda. If we haven’t done so already, Comfort [spelled
phonetically] will send an email to all of you and your administrative assistants. These
are dates that carry us two years hence to February of 2015. And please put them on your
calendar when you get that message. And with that, I’m ready to turn this over to Eric
for the director’s report. [end of transcript]

Leave a Reply

Your email address will not be published. Required fields are marked *